Cargando…
HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754454/ https://www.ncbi.nlm.nih.gov/pubmed/32672888 http://dx.doi.org/10.1002/cbic.202000351 |
_version_ | 1783626199017193472 |
---|---|
author | Schiedel, Matthias Lehotzky, Attila Szunyogh, Sandor Oláh, Judit Hammelmann, Sören Wössner, Nathalie Robaa, Dina Einsle, Oliver Sippl, Wolfgang Ovádi, Judit Jung, Manfred |
author_facet | Schiedel, Matthias Lehotzky, Attila Szunyogh, Sandor Oláh, Judit Hammelmann, Sören Wössner, Nathalie Robaa, Dina Einsle, Oliver Sippl, Wolfgang Ovádi, Judit Jung, Manfred |
author_sort | Schiedel, Matthias |
collection | PubMed |
description | We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called proteolysis‐targeting chimera (PROTAC) enabled small‐molecule‐induced degradation of Sirt2. Herein, we report the structure‐based development of a chloroalkylated SirReal that induces the degradation of Sirt2 mediated by Halo‐tagged E3 ubiquitin ligases. Using this orthogonal approach for Sirt2 degradation, we show that other E3 ligases than cereblon, such as the E3 ubiquitin ligase parkin, can also be harnessed for small‐molecule‐induced Sirt2 degradation, thereby emphasizing the great potential of parkin to be used as an E3 ligase for new PROTACs approaches. Thus, our study provides new insights into targeted protein degradation in general and Sirt2 degradation in particular. |
format | Online Article Text |
id | pubmed-7754454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77544542020-12-28 HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) Schiedel, Matthias Lehotzky, Attila Szunyogh, Sandor Oláh, Judit Hammelmann, Sören Wössner, Nathalie Robaa, Dina Einsle, Oliver Sippl, Wolfgang Ovádi, Judit Jung, Manfred Chembiochem Full Papers We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called proteolysis‐targeting chimera (PROTAC) enabled small‐molecule‐induced degradation of Sirt2. Herein, we report the structure‐based development of a chloroalkylated SirReal that induces the degradation of Sirt2 mediated by Halo‐tagged E3 ubiquitin ligases. Using this orthogonal approach for Sirt2 degradation, we show that other E3 ligases than cereblon, such as the E3 ubiquitin ligase parkin, can also be harnessed for small‐molecule‐induced Sirt2 degradation, thereby emphasizing the great potential of parkin to be used as an E3 ligase for new PROTACs approaches. Thus, our study provides new insights into targeted protein degradation in general and Sirt2 degradation in particular. John Wiley and Sons Inc. 2020-08-27 2020-12-01 /pmc/articles/PMC7754454/ /pubmed/32672888 http://dx.doi.org/10.1002/cbic.202000351 Text en © 2020 The Authors. Published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Full Papers Schiedel, Matthias Lehotzky, Attila Szunyogh, Sandor Oláh, Judit Hammelmann, Sören Wössner, Nathalie Robaa, Dina Einsle, Oliver Sippl, Wolfgang Ovádi, Judit Jung, Manfred HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) |
title | HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
|
title_full | HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
|
title_fullStr | HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
|
title_full_unstemmed | HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
|
title_short | HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
|
title_sort | halotag‐targeted sirtuin‐rearranging ligand (sirreal) for the development of proteolysis‐targeting chimeras (protacs) against the lysine deacetylase sirtuin 2 (sirt2) |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754454/ https://www.ncbi.nlm.nih.gov/pubmed/32672888 http://dx.doi.org/10.1002/cbic.202000351 |
work_keys_str_mv | AT schiedelmatthias halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT lehotzkyattila halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT szunyoghsandor halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT olahjudit halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT hammelmannsoren halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT wossnernathalie halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT robaadina halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT einsleoliver halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT sipplwolfgang halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT ovadijudit halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 AT jungmanfred halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2 |